US 10865403
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
granted A61KA61K31/7076A61K38/00
Quick answer
US patent 10865403 (Engineered primate cystine/cysteine degrading enzymes for therapeutic uses) held by The Board of Regents of the University of Texas System expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/7076, A61K38/00, A61K38/16, A61K38/38